Cargando…

The LLP risk model: an individual risk prediction model for lung cancer

Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Sig...

Descripción completa

Detalles Bibliográficos
Autores principales: Cassidy, A, Myles, J P, van Tongeren, M, Page, R D, Liloglou, T, Duffy, S W, Field, J K
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361453/
https://www.ncbi.nlm.nih.gov/pubmed/18087271
http://dx.doi.org/10.1038/sj.bjc.6604158
_version_ 1782153214625316864
author Cassidy, A
Myles, J P
van Tongeren, M
Page, R D
Liloglou, T
Duffy, S W
Field, J K
author_facet Cassidy, A
Myles, J P
van Tongeren, M
Page, R D
Liloglou, T
Duffy, S W
Field, J K
author_sort Cassidy, A
collection PubMed
description Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Significant risk factors were fitted into multivariate conditional logistic regression models. The final multivariate model was combined with age-standardised lung cancer incidence data to calculate absolute risk estimates. Combinations of lifestyle risk factors were modelled to create risk profiles. For example, a 77-year-old male non-smoker, with a family history of lung cancer (early onset) and occupational exposure to asbestos has an absolute risk of 3.17% (95% CI, 1.67–5.95). Choosing a 2.5% cutoff to trigger increased surveillance, gave a sensitivity of 0.62 and specificity of 0.70, while a 6.0% cutoff gave a sensitivity of 0.34 and specificity of 0.90. A 10-fold cross validation produced an AUC statistic of 0.70, indicating good discrimination. If independent validation studies confirm these results, the LLP risk models’ application as the first stage in an early detection strategy is a logical evolution in patient care.
format Text
id pubmed-2361453
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-23614532009-09-10 The LLP risk model: an individual risk prediction model for lung cancer Cassidy, A Myles, J P van Tongeren, M Page, R D Liloglou, T Duffy, S W Field, J K Br J Cancer Clinical Study Using a model-based approach, we estimated the probability that an individual, with a specified combination of risk factors, would develop lung cancer within a 5-year period. Data from 579 lung cancer cases and 1157 age- and sex-matched population-based controls were available for this analysis. Significant risk factors were fitted into multivariate conditional logistic regression models. The final multivariate model was combined with age-standardised lung cancer incidence data to calculate absolute risk estimates. Combinations of lifestyle risk factors were modelled to create risk profiles. For example, a 77-year-old male non-smoker, with a family history of lung cancer (early onset) and occupational exposure to asbestos has an absolute risk of 3.17% (95% CI, 1.67–5.95). Choosing a 2.5% cutoff to trigger increased surveillance, gave a sensitivity of 0.62 and specificity of 0.70, while a 6.0% cutoff gave a sensitivity of 0.34 and specificity of 0.90. A 10-fold cross validation produced an AUC statistic of 0.70, indicating good discrimination. If independent validation studies confirm these results, the LLP risk models’ application as the first stage in an early detection strategy is a logical evolution in patient care. Nature Publishing Group 2008-01-29 2007-12-18 /pmc/articles/PMC2361453/ /pubmed/18087271 http://dx.doi.org/10.1038/sj.bjc.6604158 Text en Copyright © 2008 Cancer Research UK https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/.
spellingShingle Clinical Study
Cassidy, A
Myles, J P
van Tongeren, M
Page, R D
Liloglou, T
Duffy, S W
Field, J K
The LLP risk model: an individual risk prediction model for lung cancer
title The LLP risk model: an individual risk prediction model for lung cancer
title_full The LLP risk model: an individual risk prediction model for lung cancer
title_fullStr The LLP risk model: an individual risk prediction model for lung cancer
title_full_unstemmed The LLP risk model: an individual risk prediction model for lung cancer
title_short The LLP risk model: an individual risk prediction model for lung cancer
title_sort llp risk model: an individual risk prediction model for lung cancer
topic Clinical Study
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2361453/
https://www.ncbi.nlm.nih.gov/pubmed/18087271
http://dx.doi.org/10.1038/sj.bjc.6604158
work_keys_str_mv AT cassidya thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT mylesjp thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT vantongerenm thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT pagerd thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT liloglout thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT duffysw thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT fieldjk thellpriskmodelanindividualriskpredictionmodelforlungcancer
AT cassidya llpriskmodelanindividualriskpredictionmodelforlungcancer
AT mylesjp llpriskmodelanindividualriskpredictionmodelforlungcancer
AT vantongerenm llpriskmodelanindividualriskpredictionmodelforlungcancer
AT pagerd llpriskmodelanindividualriskpredictionmodelforlungcancer
AT liloglout llpriskmodelanindividualriskpredictionmodelforlungcancer
AT duffysw llpriskmodelanindividualriskpredictionmodelforlungcancer
AT fieldjk llpriskmodelanindividualriskpredictionmodelforlungcancer